![](/img/cover-not-exists.png)
Risedronate may preserve bone microarchitecture in breast cancer survivors on aromatase inhibitors: A randomized, controlled clinical trial
Prasad, Chaithra, Greenspan, Susan L., Vujevich, Karen T., Brufsky, Adam, Lembersky, Barry C., van Londen, G.J., Jankowitz, Rachel C., Puhalla, Shannon L., Rastogi, Priya, Perera, SubashanLanguage:
english
Journal:
Bone
DOI:
10.1016/j.bone.2016.03.010
Date:
March, 2016
File:
PDF, 274 KB
english, 2016